Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...

Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...

Affordable, multipurpose and effective beauty products that are flying just below the radar are one of our favorite topics to ...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...

Let's uncover the hidden truths behind why your eczema keeps returning and what you can do to get long-term relief.

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

Researchers have found in DELTA China trial that delgocitinib cream (Anzupgo) 20 mg/g significantly reduces severity of ...